Skip to main content

Table 2 Multiplicity of infection in clinical isolates

From: Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity, clonality and drug resistance markers

Isolate Sample pfmsp1 pfmsp2 Minimum number of clones*
K1 MAD20 RO33 FC27 IC Per sample Per isolate
HL1204 Kenya Day 0 pre-treatment 0 1 2 0 1 3 4
Day 1 post-treatment 0 2 2 0 1 4
Culture-adapted 0 1 1 0 1 2
HL1205 Nigeria Day 0 pre-treatment 1 0 1 3 1 4 5
Day 1 post-treatment 2 0 1 4 1 5
Culture-adapted 2 0 2 3 1 4
HL1209 South Sudan Day 0 pre-treatment 0 2 2 4 2 6 6
Day 1 post-treatment 0 1 2 4 2 6
Culture-adapted 0 2 2 4 2 6
HL1210 Ghana Day 0 pre-treatment 2 2 0 0 1 4 4
Day 1 post-treatment 2 2 0 0 1 4
Culture-adapted 2 2 0 0 1 4
HL1211 Ghana Day 0 pre-treatment 2 0 0 0 3 3 6
Day 1 post-treatment 2 0 0 0 3 3
Culture-adapted 1 0 2 4 2 6
HL1212 Nigeria Day 0 pre-treatment 3 2 1 2 1 6 6
Culture-adapted 2 1 0 3 1 4
HL1214 Burkina Faso Day 0 pre-treatment 0 1 1 0 2 2 2
Day 1 post-treatment 0 0 0 0 0 0
Culture-adapted 0 1 1 0 2 2
  1. *The minimum number of clones in each sample was estimated by adding the highest number of bands for each Pfmsp allele.
  2. No Day 1 post-treatment sample was obtained for HL1212.